Mario Niepel

12PUBLICATIONS
41CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Proteomics and intermolecular interactions (excl. medical proteomics)AllergySignal transduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 27, 2025
Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma.

Rotem Leshem, Kieran Neil Sefton, Chun Wai Wong

|Sep 25, 2024
Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.

Pulak Kar, Chatrin Chatrin, Nina Đukić

|Jun 04, 2024
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.

Pulak Kar, Chatrin Chatrin, Nina Đukić

|Sep 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models.

Chun Wai Wong, Christos Evangelou, Kieran N Sefton

|Nov 14, 2022
Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop.

Caitlin E Mills, Kartik Subramanian, Marc Hafner

|Jul 11, 2022
Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response.

Alex M Eddie, Kevin W Chen, Laurie B Schenkel

Pageof 2

Frequent Collaborators

5 joint publications

Marc Hafner

3 joint publications

Peter K Sorger

3 joint publications

Ivan Ahel

2 joint publications

Kang Zhu